Lundbeck wins U.S. backing that may extend use of anti-depressant

COPENHAGEN (Reuters) - Denmark's Lundbeck said on Thursday a U.S. Food and Drug Administration (FDA) committee had recommended that its anti-depression drug Brintellix can add improved cognitive functions to its information leaflet, a first of its kind.

http://ift.tt/xePdMM

from Reuters: Health News
via animenewspro